This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n14http://linked.opendata.cz/resource/drugbank/drug/DB03501/identifier/chebi/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/mesh/concept/
n16http://linked.opendata.cz/resource/drugbank/drug/DB03501/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03501/identifier/kegg-compound/
n17http://linked.opendata.cz/resource/drugbank/drug/DB03501/identifier/pubchem-compound/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://linked.opendata.cz/resource/drugbank/drug/DB03501/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03501/identifier/drugbank/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03501
rdf:type
n3:Drug
n3:description
A nucleoside diphosphate sugar which can be epimerized into UDPglucose for entry into the mainstream of carbohydrate metabolism. Serves as a source of galactose in the synthesis of lipopolysaccharides, cerebrosides, and lactose. [PubChem]
n3:group
experimental
owl:sameAs
n9:DB03501 n10:DB03501
dcterms:title
Uridine Diphosphate Galactose
adms:identifier
n12:DB03501 n13:C00052 n14:18307 n15:46507114 n16:GDU n17:46936243
n3:synonym
UDP galactose Uridine 5'-diphosphate galactose UDP-gal Uridinediphosphate galactose UDP-d-galactose Uridine pyrophosphogalactose GALACTOSE-URIDINE-5'-DIPHOSPHATE Uridine diphosphogalactose GDU Uridine diphosphate-d-galactose UDPgal Uridine 5'-diphosphogalactose UDP-alpha-d-galactose UDP-galactose UPG UDP-D-Galactopyranose UDP-galactopyranose Uridinediphosphogalactose
n5:hasConcept
n6:M0022346
n3:IUPAC-Name
n4:271B4E47-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4E4D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4E4C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4E49-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4E4A-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4E4B-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4E45-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4E46-363D-11E5-9242-09173F13E4C5 n4:271B4E43-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4E44-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4E53-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4E54-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4E4E-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4E4F-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4E51-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4E50-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4E52-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
2956-16-3
n3:Bioavailability
n4:271B4E59-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4E5B-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4E5C-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4E58-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4E57-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4E5A-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4E48-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4E55-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4E56-363D-11E5-9242-09173F13E4C5